✦ LIBER ✦
The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone
✍ Scribed by Fred Saad; Dean Ruether; Scott Ernst; Scott North; Tina Cheng; Paul Perrotte; Pierre Karakiewicz; Eric Winquist
- Book ID
- 109054104
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 147 KB
- Volume
- 102
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.